Compare Stocks: CURLF, COO, GMED, and WILYY

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
COO Cooper Companies	$55.38	$68.34	$51.01 ▼ $89.83	$10.53B	0.82	4.73 million shs	4.45 million shs
CURLF Curaleaf	$11.07 -1.3%	$9.68	$5.40 ▼ $15.15	$2.58B	1.57	203,397 shs	118,482 shs
GMED Globus Medical	$74.56 +0.4%	$79.69	$55.16 ▼ $101.40	$10.01B	0.95	1.44 million shs	1.56 million shs
WILYY Demant A/S	$23.14 -3.0%	$22.33	$13.45 ▼ $23.85	$9.80B	1.2	362 shs	772 shs

7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
COO Cooper Companies	0.00%	+0.16%	-21.96%	-22.02%	-18.98%
CURLF Curaleaf	0.00%	+5.73%	+18.27%	+204.12%	+35.49%
GMED Globus Medical	0.00%	+0.67%	-9.70%	-13.35%	+34.51%
WILYY Demant A/S	0.00%	-2.98%	+2.39%	+20.21%	+24.95%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
COO Cooper Companies	$55.38	$68.34	$51.01 ▼ $89.83	$10.53B	0.82	4.73 million shs	4.45 million shs
CURLF Curaleaf	$11.07 -1.3%	$9.68	$5.40 ▼ $15.15	$2.58B	1.57	203,397 shs	118,482 shs
GMED Globus Medical	$74.56 +0.4%	$79.69	$55.16 ▼ $101.40	$10.01B	0.95	1.44 million shs	1.56 million shs
WILYY Demant A/S	$23.14 -3.0%	$22.33	$13.45 ▼ $23.85	$9.80B	1.2	362 shs	772 shs

7 Stocks That Will Be Magnificent in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
COO Cooper Companies	0.00%	+0.16%	-21.96%	-22.02%	-18.98%
CURLF Curaleaf	0.00%	+5.73%	+18.27%	+204.12%	+35.49%
GMED Globus Medical	0.00%	+0.67%	-9.70%	-13.35%	+34.51%
WILYY Demant A/S	0.00%	-2.98%	+2.39%	+20.21%	+24.95%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
COO Cooper Companies	2.16	Hold	$71.47	29.05% Upside
CURLF Curaleaf	3.60	Strong Buy	N/A	N/A
GMED Globus Medical	2.88	Moderate Buy	$101.77	36.49% Upside
WILYY Demant A/S	2.60	Moderate Buy	N/A	N/A

Current Analyst Ratings Breakdown

Latest CURLF, COO, GMED, and WILYY Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/18/2026	COO Cooper Companies	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D) ➝ Hold (C-)
9/18/2026	GMED Globus Medical	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral
9/11/2026	COO Cooper Companies	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell
9/10/2026	COO Cooper Companies	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target	Outperform	$85.00 ➝ $75.00
9/10/2026	COO Cooper Companies	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral	$80.00 ➝ $60.00
9/10/2026	COO Cooper Companies	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target	Equal Weight	$66.00 ➝ $61.00
9/10/2026	COO Cooper Companies	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Negative
9/10/2026	COO Cooper Companies	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target	Buy	$85.00 ➝ $70.00
9/10/2026	COO Cooper Companies	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target	Outperform ➝ Neutral	$85.00 ➝ $61.00
9/10/2026	COO Cooper Companies	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Overweight ➝ Neutral	$86.00 ➝ $59.00
9/10/2026	COO Cooper Companies	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Outperform ➝ Neutral	$85.00 ➝ $61.00

(Data available from 9/27/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
COO Cooper Companies	$4.24B	2.49	$6.05 per share	9.15	$43.80 per share	1.26
CURLF Curaleaf	$1.27B	2.04	$0.16 per share	67.32	$3.34 per share	3.31
GMED Globus Medical	$2.94B	3.41	$6.29 per share	11.86	$33.86 per share	2.20
WILYY Demant A/S	$3.48B	2.82	$0.88 per share	26.33	$3.51 per share	6.59

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
COO Cooper Companies	$374.90M	$2.93	18.90	11.73	2.25	13.46%	10.90%	7.24%	12/3/2026 (Estimated)
CURLF Curaleaf	-$231.07M	-$0.13	N/A	N/A	N/A	-2.62%	-0.88%	-0.26%	N/A
GMED Globus Medical	$537.87M	$3.91	19.07	13.83	1.20	17.02%	14.57%	12.62%	11/5/2026 (Estimated)
WILYY Demant A/S	$233.91M	N/A	N/A	19.28	N/A	N/A	N/A	N/A	N/A

Latest CURLF, COO, GMED, and WILYY Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/9/2026	Q3 2026	COO Cooper Companies	$1.12	$1.15	+$0.03	$2.24	$1.10 billion	$1.07 billion
8/6/2026	Q2 2026	GMED Globus Medical	$1.10	$1.34	+$0.24	$1.10	$782.88 million	$789.61 million
8/5/2026	Q2 2026	CURLF Curaleaf	-$0.20	$0.05	+$0.25	$0.05	$332.00 million	$340.10 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
COO Cooper Companies	N/A	N/A	-100.00%	N/A	N/A
CURLF Curaleaf	N/A	N/A	N/A	N/A	N/A
GMED Globus Medical	N/A	N/A	N/A	N/A	N/A
WILYY Demant A/S	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
COO Cooper Companies	0.23	1.22	0.73
CURLF Curaleaf	1.06	1.52	0.73
GMED Globus Medical	N/A	4.62	2.93
WILYY Demant A/S	1.65	1.36	1.00

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
COO Cooper Companies	24.39%
CURLF Curaleaf	0.03%
GMED Globus Medical	95.16%
WILYY Demant A/S	N/A

Insider Ownership

Company	Insider Ownership
COO Cooper Companies	2.08%
CURLF Curaleaf	N/A
GMED Globus Medical	18.38%
WILYY Demant A/S	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
COO Cooper Companies	15,000	190.16 million	186.20 million	Optionable
CURLF Curaleaf	5,554	233.51 million	N/A	Not Optionable
GMED Globus Medical	6,000	134.26 million	109.59 million	Optionable
WILYY Demant A/S	26,704	423.51 million	N/A	Not Optionable

CURLF, COO, GMED, and WILYY Headlines

Recent News About These Companies

Demant A/S Unsponsored ADR (OTCMKTS:WILYY) Stock Short Interest Falls 96.3%

September 26 at 3:43 AM | americanbankingnews.com

Jyske Bank downgrades Demant A to hold from buy

September 24 at 10:27 AM | msn.com

Cours Demant A/S Deutsche Boerse AG

September 23, 2026 | zonebourse.comZ

Demant stock gains as Jefferies keeps a 345 DKK target

September 23, 2026 | ad-hoc-news.deA

Demant stock trades near DKK 160 after Copenhagen market data

September 22, 2026 | ad-hoc-news.deA

Demant stock holds near 52-week high as investors weigh first-half performance

September 21, 2026 | ad-hoc-news.deA

Demant stock heads into the open after a recent Copenhagen gain

September 21, 2026 | ad-hoc-news.deA

Demant stock gains as investors digest solid first-half figures

September 20, 2026 | ad-hoc-news.deA

Demant stock gains as analysts highlight valuation after strong first-half figures

September 20, 2026 | ad-hoc-news.deA

Demant stock gains as Oddo raises price target to 275 DKK

September 18, 2026 | ad-hoc-news.deA

Demant stock heads into the open after a modest gain

September 9, 2026 | ad-hoc-news.deA

Demant A/S (WILYY) Q2 2026 Earnings Call Transcript

August 12, 2026 | seekingalpha.com

Demant A/S: Demant-owned Oticon announces launch of new flagship hearing aids

August 12, 2026 | finanznachrichten.de

Demant AS ADR WILYY

August 7, 2026 | morningstar.comM

Demant A/S : Jyske Bank n'est plus positif

August 6, 2026 | zonebourse.comZ

Demant’s Latest AI Hearing Aid Fuels Best Quarter in 26 Years

June 26, 2026 | bloomberg.com

Demant shares surge 15% after Oticon Zeal drives Q1 growth

May 7, 2026 | za.investing.com

Demant A/S: Expansion of Demant's Executive Leadership Team

May 6, 2026 | finanznachrichten.de

Jefferies flips on hearing aid giants, upgrades Demant, cuts Sonova

March 18, 2026 | investing.com

3 European Stocks Estimated To Be Trading At Over 49.3% Below Intrinsic Value

February 18, 2026 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

CURLF, COO, GMED, and WILYY Company Descriptions

Cooper Companies NASDAQ:COO

$55.38 0.00 (0.00%)

Closing price 09/25/2026 04:00 PM Eastern

Extended Trading

$55.28 -0.10 (-0.18%)

As of 09/25/2026 07:55 PM Eastern

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Curaleaf OTCMKTS:CURLF

$11.07 -0.15 (-1.34%)

As of 09/25/2026 03:57 PM Eastern

Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. The company is headquartered in New York, New York.

Globus Medical NYSE:GMED

$74.56 +0.29 (+0.39%)

Closing price 09/25/2026 03:59 PM Eastern

Extended Trading

$74.94 +0.38 (+0.51%)

As of 09/25/2026 07:55 PM Eastern

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Demant A/S OTCMKTS:WILYY

$23.14 -0.71 (-2.98%)

As of 09/25/2026 12:36 PM Eastern

Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally. It operates through two segments: Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services. The Communications segment provides headsets and solutions for the professional call centers, office markets, and gaming markets under the EPOS brand name. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CURLF, COO, GMED, and WILYY Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CURLF, COO, GMED, and WILYY Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CURLF, COO, GMED, and WILYY Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

CURLF, COO, GMED, and WILYY Company Descriptions

Cooper Companies NASDAQ:COO

Curaleaf OTCMKTS:CURLF

Globus Medical NYSE:GMED

Demant A/S OTCMKTS:WILYY

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CURLF, COO, GMED, and WILYY Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CURLF, COO, GMED, and WILYY Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CURLF, COO, GMED, and WILYY Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

CURLF, COO, GMED, and WILYY Company Descriptions

Cooper Companies NASDAQ:COO

Curaleaf OTCMKTS:CURLF

Globus Medical NYSE:GMED

Demant A/S OTCMKTS:WILYY

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools